Business, energy, technology, markets and global industry news from Business News Today

carbachol and brimonidine tartrate ophthalmic solution

PharmaDeviceNews carbachol and brimonidine tartrate ophthalmic solution
Representative image of prescription eye drops and reading glasses, illustrating how Tenpoint Therapeutics and PHIL are using a direct-to-patient YUVEZZI access program to improve affordability and expand presbyopia treatment access.
Pharma & Biotech

Can Tenpoint Therapeutics’ direct-to-patient YUVEZZI program unlock wider access in the presbyopia market?

Tenpoint Therapeutics and PHIL launch YUVEZZI direct-to-patient access for presbyopia. Read what it means for affordability, uptake, and market adoption.

Read More
Tenpoint’s YUVEZZI sets new benchmark in presbyopia eye drop efficacy and safety
Pharma & Biotech

Tenpoint’s YUVEZZI sets new benchmark in presbyopia eye drop efficacy and safety

YUVEZZI becomes the first FDA-approved dual-agent eye drop for presbyopia. Find out what this means for Tenpoint Therapeutics and the future of vision care.

Read More